ArticleOphthalmology and therapy2024

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Marco A Zarbin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.